Stelo by Dexcom

Press Releases

Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available

DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter glucose biosensor in the U.S., is now available for purchase without a prescription4 at Stelo.com. “In a world where GLP-1 use is becoming increasingly more common, glucose biosensors like Stelo can help make those medications more effective.12”Post this Stelo is…